Research feed
Recently published diabetes studies added to Dediabetes, summarized and organized by intervention and outcome.
Sorted by publication date. Some studies may have been added to Dediabetes later.
This study evaluated the combination therapy of Dapagliflozin and Linagliptin in managing Type 2 Diabetes and hypertension, showing significant improvements in various health metrics.
The study evaluated the effects of a curcumin-piperine combination on mental health and physical factors in diabetic retinopathy patients, showing significant improvements in various outcomes.
This study evaluated the efficacy and safety of Bifidobacterium longum subsp. longum BL21 as an adjunctive therapy to metformin in patients with type 2 diabetes, finding a significant reduction in HbA1c levels.
This study evaluated the effects of a combined arm rotation and walking exercise regimen on glycemic control in type 2 diabetes, finding significant reductions in postprandial blood glucose and HbA1c levels.
This study evaluated the effects of semaglutide combined with insulin therapy on glycemic control and renal function in elderly patients with type 2 diabetes, finding significant improvements in several metabolic parameters.
The study evaluated the effects of a diabetes-specific nutritional formula (DSNF-Pro) on postprandial glycemic control in prediabetic participants, finding significant reductions in glucose and c-peptide levels compared to a standard formula.
This study compared the effectiveness of nutritional therapy and alpha-glucosidase inhibitors in managing type 2 diabetes, finding significant reductions in glucose levels with both interventions.
This study examined the impact of continuous glucose monitoring on glycemic control in diabetes patients, finding significant reductions in HbA1c and fasting plasma glucose levels.
This study evaluated the effects of mulberry twig alkaloids combined with continuous subcutaneous insulin infusion on glycemic variability in type 2 diabetes patients, finding significant improvements in several glycemic metrics.
Switching from premixed insulin to the insulin glargine/lixisenatide fixed-ratio combination (iGlarLixi) improved glycemic control in participants with type 2 diabetes.
Latest Evidence
Build your workspace to keep track of the latest diabetes research.
